In silico identification of novel lncRNAs with a potential role in diagnosis of gastric cancer

References

• Balas, M. M., & Johnson, A. M. (2018). Exploring the mechanisms behind long noncoding RNAs and cancer. Non-coding RNA Research, 3, 108–117.
   PubMedGoogle Scholar
• Baratieh, Z., Khalaj, Z., Honardoost, M. A., Emadi-Baygi, M., Khanahmad, H., Salehi, M., & Nikpour, P. (2017). Aberrant expression of PlncRNA-1 and TUG1: Potential biomarkers for gastric cancer diagnosis and clinically monitoring cancer progression. Biomarkers in Medicine, 11(12), 1077–1090. doi:10.2217/bmm-2017-0090
   PubMed Web of Science ®Google Scholar
• Chakravarthi, B. V., Nepal, S., & Varambally, S. (2016). Genomic and epigenomic alterations in cancer. The American Journal of Pathology, 186(7), 1724–1735. doi:10.1016/j.ajpath.2016.02.023
   PubMed Web of Science ®Google Scholar
• Chen, M., Wu, X., Ma, W., Zhou, Q., Wang, X., Zhang, R., … Yang, X. (2017). Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomarkers, 21, 23–28.
   PubMed Web of Science ®Google Scholar
• Chen, S-X., Yin, J-F., Lin, B-C., Su, H-F., Zheng, Z., Xie, C-y., & Fei, Z-h. (2016). Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biology, 37(5), 6801–6812. doi:10.1007/s13277-015-4404-0
   PubMedGoogle Scholar
• Delshad, E., Shafiee, M., Maghsoudi, H., Shamsabadi, F., & Bahramian, S. (2018). Identification of novel miRNAs with potential role in Gastric Cancer diagnosis: In silico procedure. Meta Gene, 19, 246–252.
   Web of Science ®Google Scholar
• Deng, N., Goh, L. K., Wang, H., Das, K., Tao, J., Tan, I. B., … Lim, K. H. (2012). A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut, 61, 673–684.
   PubMed Web of Science ®Google Scholar
• Du, D. X., Lian, D. B., Amin, B. H., & Yan, W. (2017). Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer. European Review for Medical and Pharmacological Sciences, 21, 5392–5398.
   PubMed Web of Science ®Google Scholar
• Gibb, E. A., Brown, C. J., & Lam, W. L. (2011). The functional role of long non-coding RNA in human carcinomas. Molecular Cancer, 10(1), 38. doi:10.1186/1476-4598-10-38
   PubMed Web of Science ®Google Scholar
• Goyal, A., Fiškin, E., Gutschner, T., Polycarpou-Schwarz, M., Groß, M., Neugebauer, J., … Diederichs, S. (2017). A cautionary tale of sense-antisense gene pairs: Independent regulation despite inverse correlation of expression. Nucleic Acids Research, 45(21), 12496–12508. doi:10.1093/nar/gkx952
   PubMed Web of Science ®Google Scholar
• Huarte, M. (2015). The emerging role of lncRNAs in cancer. Nature Medicine, 21(11), 1253doi:10.1038/nm.3981
   PubMed Web of Science ®Google Scholar
• Jansson, M. D., & Lund, A. H. (2012). MicroRNA and cancer. Molecular Oncology, 6(6), 590–610. doi:10.1016/j.molonc.2012.09.006
   PubMed Web of Science ®Google Scholar
• Ke, D., Li, H., Zhang, Y., An, Y., Fu, H., Fang, X., & Zheng, X. (2017). The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget, 8(13), 21516. doi:10.18632/oncotarget.15628
   PubMed Web of Science ®Google Scholar
• Li, J., Gao, J., Tian, W., Li, Y., & Zhang, J. (2017). Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297. Cancer Cell International, 17(1), 44.doi:10.1186/s12935-017-0408-8
   PubMedGoogle Scholar
• Li, Y., Lv, S., Ning, H., Li, K., Zhou, X., Xv, H., & Wen, H. (2018). Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Biomedicine & Pharmacotherapy, 108, 1775–1782. doi:10.1016/j.biopha.2018.09.181
   PubMed Web of Science ®Google Scholar
• Liu, J., Yang, C., Gu, Y., Li, C., Zhang, H., Zhang, W., … Zheng, C. (2018). Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma. Cellular & Molecular Biology Letters, 23(1), 17.
   PubMedGoogle Scholar
• Mabula, J. B., Mchembe, M. D., Koy, M., Chalya, P. L., Massaga, F., Rambau, P. F., … Jaka, H. (2012). Gastric cancer at a university teaching hospital in northwestern Tanzania: A retrospective review of 232 cases. World Journal of Surgical Oncology, 10(1), 257. doi:10.1186/1477-7819-10-257
   PubMedGoogle Scholar
• Moghimbeigi, A., Tapak, L., Roshanaei, G., & Mahjub, H. (2014). Survival analysis of gastric cancer patients with incomplete data. Journal of Gastric Cancer, 14(4), 259–265. doi:10.5230/jgc.2014.14.4.259
   PubMedGoogle Scholar
• Nie, F., Yu, X., Huang, M., Wang, Y., Xie, M., Ma, H., … Sun, M. (2017). Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget, 8(24), 38227.
   PubMedGoogle Scholar
• Pang, K., Ran, M.‐J., Zou, F.‐W., Yang, T.‐W., & He, F. (2018). Long non‐coding RNA LINC00857 promotes gastric cancer cell proliferation and predicts poor patient survival. Oncology Letters, 16(2), 2119–2124.
   PubMed Web of Science ®Google Scholar
• Park, M., & Hong, J. (2016). Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells, 5(2), 15. doi:10.3390/cells5020015
   PubMed Web of Science ®Google Scholar
• Qiao, M., Shi, Q., & Pardee, A. B. (2010). The pursuit of oncotargets through understanding defective cell regulation. Oncotarget, 1(7), 544. doi:10.18632/oncotarget.101010
   PubMedGoogle Scholar
• Qin, Y., Zhuang, S., Wen, J., & Zheng, K. (2018). Long non‐coding RNA MDC1‐AS inhibits human gastric cancer cell proliferation and metastasis through an MDC1‐dependent mechanism. Experimental and Therapeutic Medicine, 15(1), 191–197.
   PubMed Web of Science ®Google Scholar
• Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, G. J. A., Maciejewski, R., & Polkowski, W. P. (2018). Gastric cancer: Epidemiology, prevention, classification, and treatment. Cancer Management and Research, 10, 239. doi:10.2147/CMAR.S149619
   PubMed Web of Science ®Google Scholar
• Wang, H., Chen, W., Yang, P., Zhou, J., Wang, K., & Tao, Q. (2018). Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis. Cancer Biology & Therapy, 20, 461–473.
   PubMed Web of Science ®Google Scholar
• Wang, M. W., Liu, J., Liu, Q., Xu, Q. H., Li, T. F., Jin, S., & Xia, T. S. (2017). LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression. European Review for Medical and Pharmacological Sciences, 21(20), 4613–4622.
   PubMed Web of Science ®Google Scholar
• Wang, X., Ren, M., Li, Y., Hu, J., Lu, G., Ma, W., … He, S. (2018). Long noncoding RNA NNT‐AS1 promotes gastric cancer proliferation and invasion by regulating microRNA‐363 expression. Journal of Cellular Biochemistry, 120, 5704–5712.
   PubMed Web of Science ®Google Scholar
• Wang, Z., & Zheng, Y. (2018). lncRNAs regulate innate immune responses and their roles in macrophage polarization. Mediators of Inflammation, 2018, 1. doi:10.1155/2018/8050956
   Web of Science ®Google Scholar
• Wei, Y., Yan, Z., Wu, C., Zhang, Q., Zhu, Y., Li, K., & Xu, Y. (2017). Integrated analysis of dosage effect lncRNAs in lung adenocarcinoma based on comprehensive network. Oncotarget, 8(42), 71430. doi:10.18632/oncotarget.19864
   PubMedGoogle Scholar
• Xu, T-P., Wang, W-y., Ma, P., Shuai, Y., Zhao, K., Wang, Y-F., … Zhang, E-B. (2018). Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Oncogene, 37, 5020–5036.
   PubMed Web of Science ®Google Scholar
• Xu, T-P., Xia, R., Liu, X-X., Sun, M., Yin, L., Chen, W-M., … De, W. (2014). Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. Journal of Hematology & Oncology, 7(1), 63.
   PubMedGoogle Scholar
• Yang, G., Lu, X., & Yuan, L. (2014). LncRNA: A link between RNA and cancer. Biochimica et Biophysica Acta, 1839(11), 1097–1109. doi:10.1016/j.bbagrm.2014.08.012
   PubMed Web of Science ®Google Scholar
• Zeng, S., Xie, X., Xiao, Y.-F., Tang, B., Hu, C.-J., Wang, S.-M., … Yang, S.-M. (2018). Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression. Cancer Letters, 412, 179–187. doi:10.1016/j.canlet.2017.10.026
   PubMed Web of Science ®Google Scholar
• Zhang, X.-D., Huang, G.-W., Xie, Y.-H., He, J.-Z., Guo, J.-C., Xu, X.-E., … Xu, L.-Y. (2018). The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells. Nucleic Acids Research, 46(4), 1793–1809. doi:10.1093/nar/gkx1259
   PubMed Web of Science ®Google Scholar
• Zheng, L., Chen, J., Zhou, Z., & He, Z. (2017). Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway. Tumour Biology, 39(5), 1010428317705335doi:10.1177/1010428317705335
   Google Scholar
• Zhao, S., He, Y., Yang, S., Hu, J., Zhang, Q., Chen, W., … Tang, J. (2018). The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis. Bioscience Reports, 38(5), BSR20180772. doi:10.1042/BSR20180772
   PubMedGoogle Scholar